![](/remote/aHR0cHM6Ly9naWVjZG4uYmxvYi5jb3JlLndpbmRvd3MubmV0L2ZpbGV1cGxvYWRzL2ltYWdlLzIwMTkvMDQvMjkvc291dGhfY2Fyb2xpbmFfZmxhZy1hZG9iZV9zdG9jay1jcmVkaXQtbHVsbGEtcmVzaXplZC5qcGc.VnSNIZjycv0.jpg?w=948&h=533&format=webp&mode=pad&anchor=middlecenter&scale=both&bgcolor=F0F1F2)
Top photo: © Lulla | Adobe Stock
COLUMBIA — A decision by a key Senate committee on whether to legalize marijuana for medical use in South Carolina will have to wait until next year.
The S.C. Senate’s Medical Affairs Committee, which was expected to vote Thursday on whether to advance the Compassionate Care Act, is considering a raft of late-breaking amendments, including dropping actual botanical marijuana from the bill. One amendment would only allow derivatives such as oils and creams.
The amendments are intended to further address the concerns of the bill’s opponents, such as the State Law Enforcement Division and the S.C. Medical Association, and help sway undecided senators.
Latest from Cannabis Business Times
- Navigating Cultivation Room Design: Optimization vs. Maximization
- Verano Opens 18th Medical Cannabis Dispensary in Pennsylvania
- Hundreds Interested in Kentucky’s Medical Cannabis Licenses; Just 17 Apply So Far
- Aurora Receives Expanded Cultivation, Unique Research Licenses for German Facility
- Curaleaf Opening 2 New York Medical Dispensaries, Launching Adult-Use Sales at 2 Other Stores
- Ohio’s Adult-Use Licensing Process Leads CBT’s Top Stories in July
- Planet 13 Launches Lifestyles Brand Company; Signs 1st Sponsored Athlete in UFC Title Contender Chito Vera
- LeafLink Acquires Leading Cannabis Banking Platform Dama Financial